HEL 92.1.7 In Vivo Tumorigenesis Assay

This assay is to provide HEL 92.1.7-based In Vivo Tumorigenesis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

HEL 92.1.7

Human

HEL 92.1.7 is a erythroblast cell line isolated from the bone marrow of a 30-year-old, White, male patient with erthroleukemia. This cell line can be used in immune system disorder research and immunology research.

Erythroleukemia

Oncology

In Vivo Tumorigenesis Assay

HEL 92.1.7-cell based In Vivo Tumorigenesis Assay

Tumorigenicity is defined the property of a cell to form tumors when inoculated into an immunosuppressed animal model. Generally, test cells and tumor cells as positive control are administered subcutaneously into immunosuppressed nude mice. The number of animals developing tumors are compared with a positive control reference cell line.

Oncology In Vivo Assays